(S (NP (NP (NNP Acute) (NNP Kidney) (NNP Injury)) (PRN (-LRB- -LRB-) (NP (NNP AKI)) (-RRB- -RRB-))) (VP (VBZ is) (NP (NP (DT a) (JJ common) (JJ clinical) (NN syndrome)) (VP (VBN characterized) (PP (IN by) (NP (NP (DT the) (JJ rapid) (NN loss)) (PP (IN of) (NP (NN kidney) (NN excretory) (NN function))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ aggravates) (NP (NP (DT the) (JJ clinical) (NN severity)) (PP (IN of) (NP (JJ other) (NNS diseases)))) (PP (IN in) (NP (NP (DT a) (JJ large) (NN number)) (PP (IN of) (NP (JJ hospitalized) (NNS patients))))))))))))) (. .))
(S (NP (NP (NNP Accurate) (JJ early) (NN prediction)) (PP (IN of) (NP (NNP AKI)))) (VP (MD can) (VP (VB enable) (NP (JJ in-time) (NNS interventions) (CC and) (NNS treatments)))) (. .))
(S (S (ADVP (RB However)) (, ,) (NP (NNP AKI)) (VP (VBZ is) (ADJP (RB highly) (JJ heterogeneous)))) (, ,) (ADVP (RB thus)) (S (NP (NP (NN identification)) (PP (IN of) (NP (NNP AKI) (NNS sub-phenotypes)))) (VP (MD can) (VP (VB lead) (PP (TO to) (NP (NP (NP (DT an) (JJ improved) (NN understanding)) (PP (IN of) (NP (DT the) (NN disease) (NN pathophysiology)))) (CC and) (NP (NP (NN development)) (PP (IN of) (NP (ADJP (RBR more) (JJ targeted)) (JJ clinical) (NNS interventions))))))))) (. .))
(S (NP (DT This) (NN study)) (VP (VBD used) (NP (DT a) (ADJP (NN memory) (JJ network-based)) (JJ deep) (NN learning) (NN approach)) (S (VP (TO to) (VP (VB discover) (NP (NNP AKI) (NNS sub-phenotypes)) (S (VP (VBG using) (NP (NP (ADJP (VBN structured) (CC and) (JJ unstructured)) (JJ electronic) (NN health) (NN record) (PRN (-LRB- -LRB-) (NNP EHR) (-RRB- -RRB-)) (NN data)) (PP (IN of) (NP (NP (NNS patients)) (PP (IN before) (NP (NNP AKI) (NN diagnosis)))))))))))) (. .))
(S (NP (PRP We)) (VP (VBD leveraged) (NP (NP (DT a) (JJ real) (NN world) (JJ critical) (NN care) (NNP EHR) (NN corpus)) (PP (VBG including) (NP (CD 37,486) (NNP ICU) (NNS stays))))) (. .))
(S (NP (DT These) (NNS patients)) (VP (VBP are) (ADJP (RBR more) (JJ likely) (S (VP (TO to) (VP (VB develop) (NP (NN stage) (PRP I) (NNP AKI))))))) (. .))
(S (NP (DT These) (NNS patients)) (VP (VBP are) (ADJP (RBR more) (JJ likely) (S (VP (TO to) (VP (VB develop) (NP (NN stage) (NNP III) (NNP AKI))))))) (. .))
(S (S (NP (DT Both) (NNP SCr) (CC and) (NN eGFR)) (VP (VBP are) (ADJP (RB significantly) (JJ different)) (PP (IN across) (NP (DT the) (CD three) (NNS sub-phenotypes))) (PP (IN with) (NP (NP (JJ statistical) (VBG testing)) (CC plus) (NP (JJ postdoc) (NN analysis)))))) (, ,) (CC and) (S (NP (DT the) (NN conclusion)) (ADVP (RB still)) (VP (VBZ holds) (PP (IN after) (NP (NN age) (NN adjustment))))) (. .))
